DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

Dow Jones

02-15

By Katherine Hamilton

DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company.

The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year.

Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been.

Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder.

DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level.

Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

February 14, 2025 14:35 ET (19:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2511611920"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2511611920\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2511611920?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-15 03:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2511611920","market":"other","top_or_hot":-1,"title":"DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. \n</p>\n<p>\n  The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year. \n</p>\n<p>\n  Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been. \n</p>\n<p>\n  Berkshire Chairman <a class=\"promotion-word\" href=\"https://ttm.financial/U/4180165723785092\">Warren Buffett</a> sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder. \n</p>\n<p>\n  DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level. \n</p>\n<p>\n  Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 14, 2025 14:35 ET (19:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones & Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-02-15 03:35</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. \n</p>\n<p>\n  The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year. \n</p>\n<p>\n  Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been. \n</p>\n<p>\n  Berkshire Chairman <a class=\"promotion-word\" href=\"https://ttm.financial/U/4180165723785092\">Warren Buffett</a> sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder. \n</p>\n<p>\n  DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level. \n</p>\n<p>\n  Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 14, 2025 14:35 ET (19:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones & Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRK.B","symbol_name":"伯克希爾B","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2511611920","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2511611920","pubTimestamp":1739561700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company.The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year.Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been.Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder.DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level.Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company gu","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BRK.B":"伯克希尔B","BRK.A":"伯克希尔","DVA":"达维塔保健"},"translate_title":"伯克希尔哈撒韦公司出售前景未达预期后，DaVita股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRK.A":1,"BRK.B":1,"DVA":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. \n\n\n  The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year. \n\n\n  Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been. \n\n\n  Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder. \n\n\n  DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level. \n\n\n  Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 14:35 ET (19:35 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}